A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Clinical trial NCT06976268 · RECRUITING
Trial details
- NCT number
- NCT06976268
- Sponsor
- Biohaven Therapeutics Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-28
- Primary completion
- 2027-08-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.